Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Stoke Therapeutics Inc (NASDAQ: STOK) was $19.59 for the day, down -0.86% from the previous closing price of $19.76. In other words, the price has decreased by -$0.86 from its previous closing price. On the day, 0.99 million shares were traded. STOK stock price reached its highest trading level at $20.442 during the session, while it also had its lowest trading level at $19.39.
Ratios:
Our analysis of STOK’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.55. For the most recent quarter (mrq), Quick Ratio is recorded 6.98 and its Current Ratio is at 6.98. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 18, 2025, initiated with a Buy rating and assigned the stock a target price of $30.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 02 ’25 when BARUCH TICHO bought 10,844 shares for $19.76 per share.
EDWARD M KAYE bought 61,885 shares of STOK for $1,223,466 on Aug 29 ’25. On Aug 29 ’25, another insider, JONATHAN ALLAN, who serves as the Officer of the company, bought 22,117 shares for $19.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STOK now has a Market Capitalization of 1073481088 and an Enterprise Value of 829324416. As of this moment, Stoke’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.18. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.37 while its Price-to-Book (P/B) ratio in mrq is 3.20. Its current Enterprise Value per Revenue stands at 4.149 whereas that against EBITDA is 19.619.
Stock Price History:
The Beta on a monthly basis for STOK is 1.14, which has changed by 0.26468694 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, STOK has reached a high of $20.00, while it has fallen to a 52-week low of $5.35. The 50-Day Moving Average of the stock is 37.41%, while the 200-Day Moving Average is calculated to be 77.95%.
Shares Statistics:
STOK traded an average of 751.75K shares per day over the past three months and 916470 shares per day over the past ten days. A total of 54.72M shares are outstanding, with a floating share count of 45.92M. Insiders hold about 16.21% of the company’s shares, while institutions hold 112.38% stake in the company. Shares short for STOK as of 1755216000 were 11190785 with a Short Ratio of 14.89, compared to 1752537600 on 11496684. Therefore, it implies a Short% of Shares Outstanding of 11190785 and a Short% of Float of 24.69.
